Studies of Viagra Offer Some Reassurance to Men With Concerns About Cardiac Effects

Article Abstract:

Researchers discussed the effect of Viagra on men with a heart condition at the Annual Scientific Session of the American College of Cardiology. Of the 10 million men who have allegedly taken Viagra, 130 have died. However, they may have had other risk factors for death.

Product information, Complications and side effects, Risk factors, Pfizer Inc., Heart attack, PFE, Viagra (Medication)

---

Metabolic syndrome recasts old cardiac diabetes risk factors as a "New" entity

Article Abstract:

Metabolic syndrome which indicates a heightened risk for diabetes and heart disease is explained. Treatments recommended for metabolic syndrome are weight reduction, increase in physical activity and nutrition therapy.

Management dynamics, Offices & clinics of medical doctors, Physicians & Surgeons, Offices of Physicians (except Mental Health Specialists), Practice, Physicians, Diabetes, Diabetes mellitus, Metabolic syndrome X

---

Systemic tools can improve cardiac care

Article Abstract:

A set of clinical guidelines like the appropriate drug therapy can help patients suffering from heart problems. These guidelines can reduce disparities in cardiac care and the variation seen in cardiovascular care.

Drug therapy, Heart diseases, Practice guidelines (Medicine), Cardiac patients

Similar abstracts:

• Abstracts: Use of public performance reports: a survey of patients undergoing cardiac surgery. Public Release of Performance Data: A Progress Report From the Front
• Abstracts: Presence of mutation conferring resistance to lamivudine in plasma and cerebrospinal fluid of HIV-1 infected patients
• Abstracts: Levels of testosterone and estrogen and bone density in elderly men. Androgens, estrogens, and bone in men
• Abstracts: Elevations of group II phospholipase A(sub 2) concentrations in serum and amniotic fluid in association with preterm labor
• Abstracts: Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.